Karyopharm Therapeutics Inc. - Common Stock, par value $0.0001 per share (KPTI)

CUSIP: 48576U106

Q4 2020 13F Holders as of 31 Dec 2020

Holder snapshot 7 signals
Share change
-3,915,618
Put/Call ratio
70%
SEC-reported price per share
$15.48
Number of holders
165
Value change
-$54,468,075
Number of buys
82
Open additional details 1 more signal available
Number of sells
64
Security identity Names, identifiers, and filing context for this profile. 1 source field
Shares outstanding
22,658,403

Security key

48576U106

Report period

Q4 2020

Institutions

165

Top holders

10

Ownership snapshot

Top reported holders of KPTI - Karyopharm Therapeutics Inc. - Common Stock, par value $0.0001 per share (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.

Comparable stake leader
BlackRock Finance, Inc.
Disclosed value leader
BlackRock Finance, Inc.
Comparable rows
15/15
Latest evidence
30 Sep 2020
13F Lead comparable stake: 32% Showing 1-6 of 15 holder rows.

Quick read

BlackRock Finance, Inc. leads the comparable SEC ownership view at 32%.

15 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.

Open SEC evidence Opens BlackRock Finance, Inc.'s linked filing trail.
Comparable ownership Top 5
BlackRock Finance, Inc. 32%
Avoro Capital Advisors LLC 26%
Palo Alto Investors LP 22%
STATE STREET CORP 21%
FRONTIER CAPITAL MANAGEMENT CO LLC 16%

Ownership % is shown only when SEC disclosures are safely comparable across share classes.

Detailed SEC evidence table Showing 1-6 of 15 holder rows
Holder Evidence Ownership % Position 12M Net Δ As of
BlackRock Finance, Inc.
13F
Company
13F
32%
$104,679,000
7,169,789 shares
30 Sep 2020
Avoro Capital Advisors LLC
13F
Company
13F
26%
$87,600,000
6,000,000 shares
30 Sep 2020
Palo Alto Investors LP
13F
Company
13F
22%
$74,258,000
5,086,152 shares
30 Sep 2020
STATE STREET CORP
13F
Company
13F
21%
$69,919,000
4,788,974 shares
30 Sep 2020
FRONTIER CAPITAL MANAGEMENT CO LLC
13F
Company
13F
16%
$54,075,000
3,703,786 shares
30 Sep 2020
VANGUARD GROUP INC
13F
Company
13F
15%
$50,284,000
3,444,065 shares
30 Sep 2020
How to read this table

Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

13F holder rows

Institutional holders as of Q4 2020

Investor-level positions for this CUSIP, loaded as an interactive table.

Institutions
165
Shares
63,829,194
Rows available
165
Investor Option Weight % Change % SEC-reported value * Price Shares Share Change Activity Report Period

* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.

Compare Q4 2020 vs Q4 2025 Across Filers

Q4 2025 holders
0
Q4 2020 holders
165
Holder diff
165
Investor Q4 2025 Shares Q4 2020 Shares Share Diff Share Chg % Q4 2025 value Q4 2020 value Value change Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .